Cargando…
Role of Hematopoietic Growth Factors as Adjuncts in the Treatment of Chronic Hepatitis C Patients
Drug-induced hematotoxicity is the most common reason for reducing the dose or withdrawing ribavirin (RBV) and interferon (IFN) therapy in chronic hepatitis C, which leads to the elimination of a possible cure for the patient. Traditionally, severe anemia and neutropenia have been considered as abso...
Autores principales: | Danish, Fazal A., Koul, Salman S., Subhani, Fazal R., Rabbani, Ahemd E., Yasmin, Saeeda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702921/ https://www.ncbi.nlm.nih.gov/pubmed/19568529 http://dx.doi.org/10.4103/1319-3767.41739 |
Ejemplares similares
-
Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
por: Danish, Fazal A., et al.
Publicado: (2010) -
Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010) -
Managing HCV Infection in Pediatric Age Group: Suggested Recommendations
por: Danish, Fazal A., et al.
Publicado: (2010) -
Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009) -
Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015)